Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global intravenous solutions market reached a value of US$ 12.5 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Intravenous (IV) solutions are supplemental fluids comprising water, electrolytes, sugar, and medications. They are given to patients according to their requirements, medical condition, age, and body size to restore fluid volume and treat electrolyte balance. At present, they are widely used in IV therapy to replace electrolyte losses, administer drugs and blood products, and supply essential nutrients to the intravascular fluid compartment.

Intravenous Solutions Market Trends:

Due to the sudden outbreak of coronavirus disease (COVID-19), there is a rise in the demand for IV solutions worldwide to provide essential nutrients to patients in the intensive care unit (ICU). Apart from this, the increasing number of people who have diabetes, cancer, gastrointestinal disorder, and neurological diseases represents another major growth-inducing factor. Moreover, the faster response time and higher efficacy associated with IV solution therapy is contributing to market growth. It is used to overcome chronic dehydration that can cause fatigue, memory problems, irritability, and other medical conditions. This, along with the increasing participation of individuals in physical activities, is influencing the adoption of IV solutions for a fast recovery. IV solutions are also utilized to improve skin conditions and treat migraines and hangovers. Besides this, leading manufacturers are introducing easy-to-use, portable product variants that can be used as drips at home. Additionally, due to rising environmental concerns, they are developing premixed solutions that reduce the amount of packaging waste. Furthermore, rising investments by health agencies of numerous countries in the healthcare sector are anticipated to create a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous solutions market, along with forecasts at the global and regional level from 2021-2026. Our report has categorized the market based on type and nutrients.

Breakup by Type:

  • Partial Parenteral Nutrition 
  • Total Parenteral Nutrition
     

Total parenteral nutrition is currently the most preferred type of IV solution as it helps prevent malnutrition and maintain energy.

Breakup by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids 


Due to the rising health consciousness among individuals, amino acids hold the largest market share in the market.

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Presently, North America enjoys the leading position in the market due to the increasing prevalence of chronic diseases in the region.

Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Type, Nutrients, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., Grifols S.A., and Otsuka Pharmaceutical
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Intravenous Solutions Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Type
    5.5    Market Breakup by Nutrients
    5.6    Market Breakup by Region
    5.7    Market Forecast
    5.8    SWOT Analysis
        5.8.1    Overview
        5.8.2    Strengths
        5.8.3    Weaknesses
        5.8.4    Opportunities
        5.8.5    Threats
    5.9    Value Chain Analysis
        5.9.1    Overview
        5.9.2    Research and Development
        5.9.3    Raw Material Procurement
        5.9.4    Manufacturing
        5.9.5    Marketing
        5.9.6    Distribution
        5.9.7    End-Use
    5.10    Porters Five Forces Analysis
        5.10.1    Overview
        5.10.2    Bargaining Power of Buyers
        5.10.3    Bargaining Power of Suppliers
        5.10.4    Degree of Competition
        5.10.5    Threat of New Entrants
        5.10.6    Threat of Substitutes
6   Market Breakup by Type
    6.1    Partial Parenteral Nutrition
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Total Parenteral Nutrition
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Nutrients
    7.1    Carbohydrates
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Salts and Electrolytes
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Minerals
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Vitamins
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Amino Acids
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Region
    8.1    North America
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Europe
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Asia Pacific
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Middle East and Africa
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Latin America
        8.5.1 Market Trends
        8.5.2 Market Forecast
9   Intravenous Solutions Manufacturing Process
    9.1    Product Overview
    9.2    Raw Material Requirements
    9.3    Manufacturing Process
    9.4    Key Success and Risk Factors
10   Competitive Landscape
    10.1    Market Structure
    10.2    Key Players
    10.3    Profiles of Key Players
        10.3.1    Ajinomoto
            10.3.1.1    Company Overview
            10.3.1.2    Description
            10.3.1.3    Product Portfolio
            10.3.1.4    Financials
            10.3.1.5    SWOT Analysis
        10.3.2    B. Braun Melsungen
            10.3.2.1    Company Overview
            10.3.2.2    Description
            10.3.2.3    Product Portfolio
            10.3.2.4    Financials
            10.3.2.5    SWOT Analysis
        10.3.3    Baxter International Inc.
            10.3.3.1    Company Overview
            10.3.3.2    Description
            10.3.3.3    Product Portfolio
            10.3.3.4    Financials
            10.3.3.5    SWOT Analysis
        10.3.4    Grifols
            10.3.4.1    Company Overview
            10.3.4.2    Description
            10.3.4.3    Product Portfolio
            10.3.4.4    Financials
            10.3.4.5    SWOT Analysis
        10.3.5    Otsuka Pharmaceutical
            10.3.5.1    Company Overview
            10.3.5.2    Description
            10.3.5.3    Product Portfolio

List of Figures

Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2020
Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2020
Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2020
Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
Figure 9: Global: Intravenous Solutions Industry: Porter’s Five Forces Analysis
Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million US$), 2021-2026
Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Intravenous Solutions: Raw Material Requirements
Table 6: Global: Intravenous Solutions Market: Competitive Structure
Table 7: Global: Intravenous Solutions Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Question Answered in this Report

We expect the global intravenous solutions market to grow at a CAGR of around 6% during 2021-2026.

The growing awareness towards the faster response time and higher efficacy of IV solution therapy represents one of the factors catalyzing the global intravenous solutions market.

Sudden outbreak of the COVID-19 pandemic has led to the increasing demand for intravenous solutions for health recovery of patients affected by the coronavirus to provide salt, sugar, and water directly into their venous circulation.

Based on the type, the global intravenous solutions market has been segmented into partial parenteral nutrition and total parenteral nutrition. Currently, total parental nutrition holds the majority of the total market share.

Based on the nutrients, the global intravenous solutions market can be divided into carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids. Among these, amino acids exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market. 

Some of the major players in the global intravenous solutions market include Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols, and Otsuka Pharmaceutical.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links